With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.59878-57-8,1-(Cyclopropylcarbonyl)piperazine,as a common compound, the synthetic route is as follows.
[5681 ] 3-(2-bromoethyl)- l-(4-(5-(difluoromethyl)-1 ,4-oxadiazol-2-y )-2-fluorobenzyl)- l-p henylurea (0.050 g, 0.107 mmol) and cyclopropyl(piperazin- l-yl)methanone (0.018 g, 0.1 17 mmol) were mixed at the room temperature in acetonitrile ( 1 mL) and then stirred at 100 C for 18 hr and cooled down to the room temperature to terminate the reaction. Then, water was added to the reaction mixture, followed by extraction with dichloromethane. The bi-phasic mixture was passed through a plastic frit to remove the solid residues and aqueous layer, and the organic layer collected was concentrated in vacuo. The concentrate was purified and concentrated by column chromatography (Si02 plate, 20x20x 1 mm; methanol / dichloromethane = 10 %) to give 3-(2-(4-(cyclopropanecarbonyl)piperazin-l -yl)ethyl)-l-(4-(5-(difluoromethyl)- l ,3,4-ox adiazol-2-yl)-2-fluorobenzyl)- l -phenylurea as white foam (0.024 g, 41.5 %). [5682] NMR (700 MHz, CDC13) delta 7.89 (dd, 1 H, J = 8.0, 1.7 Hz), 7.75 – 7.68 (m, 2H), 7.43 – 7.38 (m, 2H), 7.37 – 7.31 (m, 1 H), 7.21 – 7.16 (m, 2H), 6.93 (t, 1 H, 7 = 51.7 Hz), 5.06 (s, 3H), 3.44 (d, 4H, J = 34.7 Hz), 3.34 (q, 2H, J = 5.7 Hz), 2.45 (t, 2H, J = 6.0 Hz), 2.39 (s, 2H), 2.32 (s, 2H), 1.03 – 0.94 (m, 2H), 0.80 – 0.72 (m, 2H); LRMS (ES) m/z 543.3 (M+ + 1 ).
The synthetic route of 59878-57-8 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; CHONG KUN DANG PHARMACEUTICAL CORP.; LEE, Jaekwang; KIM, Yuntae; LEE, Chang Sik; SONG, Hyeseung; GWAK, Dal-Yong; LEE, Jaeyoung; OH, Jung Taek; LEE, Chang Gon; KIM, II Hyang; (1041 pag.)WO2017/23133; (2017); A2;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics